Colgate-Palmolive Co. (CL), a global dealer in consumer goods, reported first-quarter 2013 adjusted earnings of 68 cents per share. This was in line with the Zacks Consensus Estimate and up 3.0% from the year-ago quarter's adjusted earnings of 66 cents per share.
Global sales of $4,325 million were almost flat as compared with the prior-year figure of $4,215 million, as the benefit from 5% growth in volume and 1.5% rise in prices was fully offset by a negative foreign exchange rate of 6.5%. Moreover, quarterly revenues missed the Zacks Consensus Estimate of $4,342 million.
On an organic basis (excluding foreign exchange, acquisitions and divestitures), the company recorded sales growth of 6.5%.
Adjusted gross profit margin remained flat at 58.6% year over year, as the benefit from cost saving initiatives under funding-the-growth and 2012 Restructuring Program and higher pricing were fully offset by increased raw material and packaging costs.
Adjusted selling, general and administrative (SG&A) expenses, as a percentage of revenues, fell 10 basis points (bps) to 35.3% from the year-ago quarter. The decline was mainly due to lower overhead costs, partially offset by higher advertising investment, both as a percentage of sales.
In the quarter, adjusted operating profit of $1,033 million increased 2% from $985 million from the year-ago period. Consequently, operating margin improved 40 bps to 23.2%.
On a year-to-date basis, Colgate-Palmolive’s market share of global toothpaste and manual toothbrushes reached 44.3% and 33.1%, respectively. Additionally, the company’s mouthwash business made significant progress, with its global market share reaching a record of 17.3% in the year-to-date period, a 60 bps improvement from the comparable period in 2013.
North America sales (18% of total sales) rose 2.5% in the quarter, driven by a 4.5% rise in unit volume, partly offset by the negative impact of 1% each from lower pricing and foreign exchange. On an organic basis, sales increased 3.5%.
The segment’s operating profit remained flat year over year at $216 million while operating margin contracted 60 bps to 27.5%. The year-over-year decline in operating profit margin was chiefly due to lower gross profit margin and higher SG&A expenses as a percentage of net sales.
Latin America sales (27% of total sales) declined 5% year over year, as the benefit of a 6.5% increase in pricing and 4.5% unit volume growth was more than offset by a negative foreign exchange impact of 16.0%. Volume gains were most prominent in Venezuela, Brazil, Mexico and Colombia. On an organic basis, sales increased 11%.
Operating profit decreased 7% to $290 million while as a percentage of sales, it contracted 50 bps to 25.2% primarily due to a decline in gross profit margin, which was partially offset by lower SG&A expenses as a percentage of sales.
Europe/South Pacific sales (20% of total sales) grew 2% year over year, primarily benefiting from a 3.5% rise in unit volume and a 1% positive impact from foreign exchange. However, these were partially offset by a 2.5% fall in pricing. Volume gains were primarily led by the United Kingdom, Australia, France and Poland. Organic sales for the region were down 1.5%.
Operating profit increased 9% year over year to $217 million. Furthermore, the operating profit margin in the region expanded 150 bps to 25.1% primarily attributable to higher gross profit margin, partially offset by increased SG&A expenses as a percentage of sales.
Asia sales (15% of total sales) climbed 2.5%, with a 7% increase in unit volume and a 0.5% rise in pricing. These were partially offset by a 5% negative impact from foreign currency. Volume growth was primarily led by gains in India, the Greater China region, Malaysia and the Philippines. On an organic basis, sales grew 7.5%.
Operating profit rose 4% to $193 million. Operating margin expanded 30 bps to 28.7%, on account of improved gross margin.
Africa/Eurasia sales (7% of total sales) dropped 0.5% year over year due to a 10.5% negative impact from foreign currency exchange, which more than offset the benefit of 9.5% growth in unit volume and 0.5% increase in prices. Volume gains were primarily led by Russia, South Africa, Turkey and the Central Asia/Caucasus region. Organic sales for the region rose 10%.
Operating profit decreased 5% year over year to $59 million in the quarter while as a percentage of sales, it contracted 90 bps to 19.8%. The decrease was mainly due to lower gross profit margin, partially offset by fall in SG&A expenses as a percentage of sales.
Hill’s Pet Nutrition sales (13% of total sales) grew 3.5%. Unit volume increased 3.5% due to volume gains in the U.S., Russia, France and Japan, partly offset by volume declines in Canada. Pricing had a 2% positive impact on sales growth while foreign exchange negatively impacted sales by 2%. On an organic basis, sales rose 5.5% from the year-ago quarter.
Operating profit improved 6% to $144 million, while operating profit margin expanded 50 bps to 26.0%. The rise in operating margin was due to reduced SG&A expenses as a percentage of net sales partially offset by lower gross profit margin.
Other Financial Details
Colgate-Palmolive, which competes with The Procter & Gamble Co. (PG), ended the quarter with cash and cash equivalents of $1,795 million, total debt of $6,659 million and shareholders’ equity of $1,630 million. Net cash provided by operating activities came in at $820 million for the period.
Looking ahead, Colgate-Palmolive anticipates the growth momentum to continue throughout 2014 as it remains on track with its global restructuring program. Further, the company’s increased focus on funding-the-growth programs and strategic worldwide pricing endeavors should help boost its bottom line.
Other Stocks to Consider
Currently, Colgate-Palmolive carries a Zacks Rank #3 (Hold). However, some other better-ranked stocks in the consumer staples sector include Coty Inc. (COTY) and International Flavors & Fragrances Inc. (IFF). Both of these have a Zacks Rank #2 (Buy).Read the Full Research Report on PG
Read the Full Research Report on CL
Read the Full Research Report on IFF
Read the Full Research Report on COTY
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Consumer Discretionary
- gross profit margin